Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Avidity Biosciences Inc (RNA)
NASDAQ:RNA
RESEARCH TOOLSreports
RNA Stock Chart & Stats
Day’s Range― - ―
52-Week Range$13.68 - $56.00
Previous CloseN/A
Volume185.29K
Average Volume (3M)1.36M
Market Cap
$3.82B
Enterprise Value$4.09B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.90
Next Earnings
Mar 04, 2025EPS Estimate
-0.79Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.90
Shares Outstanding119,309,320
10 Day Avg. Volume1,294,423
30 Day Avg. Volume1,355,360
Standard Deviation0.23
R-Squared0.04
Alpha0.01
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)377.37
Price to Cash Flow (P/CF)-14.60
P/FCF Ratio0.00
Enterprise Value/Market Cap1.07
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit547.74
Enterprise Value/Ebitda-12.66
Forecast
1Y Price Target
$66.57Price Target Upside108.68% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
---
Bulls Say, Bears Say
Bulls Say
Enrollment ProgressThere is strong interest in enrollment for the DM1 phase 3 study, with completion on track, demonstrating confidence in the program.
Regulatory EngagementRNA is effectively engaging with FDA and global regulators on the FSHD regulatory path, indicating proactive management.
Bears Say
Competitive PressureThe stock weakness has been driven by increasing competition in the myotonic dystrophy type 1 (DM1) space and bullish commentary from a lead competitor on their potential path to accelerated approval.
---
Ownership Overview
1.57% Insiders
33.65% Mutual Funds
0.15% Other Institutional Investors
49.48% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
RNA FAQ
What was Avidity Biosciences Inc’s price range in the past 12 months?
Avidity Biosciences Inc lowest stock price was $13.68 and its highest was $56.00 in the past 12 months.
What is Avidity Biosciences Inc’s market cap?
Avidity Biosciences Inc’s market cap is $3.82B.
When is Avidity Biosciences Inc’s upcoming earnings report date?
Avidity Biosciences Inc’s upcoming earnings report date is Mar 04, 2025 which is in 11 days.
How were Avidity Biosciences Inc’s earnings last quarter?
Avidity Biosciences Inc released its earnings results on Nov 07, 2024. The company reported -$0.65 earnings per share for the quarter, beating the consensus estimate of -$0.711 by $0.061.
Is Avidity Biosciences Inc overvalued?
According to Wall Street analysts Avidity Biosciences Inc’s price is currently Undervalued.
Does Avidity Biosciences Inc pay dividends?
Avidity Biosciences Inc does not currently pay dividends.
What is Avidity Biosciences Inc’s EPS estimate?
Avidity Biosciences Inc’s EPS estimate is -0.79.
How many shares outstanding does Avidity Biosciences Inc have?
Avidity Biosciences Inc has 119,309,320 shares outstanding.
What happened to Avidity Biosciences Inc’s price movement after its last earnings report?
Avidity Biosciences Inc reported an EPS of -$0.65 in its last earnings report, beating expectations of -$0.711. Following the earnings report the stock price went down -1.663%.
Which hedge fund is a major shareholder of Avidity Biosciences Inc?
Currently, no hedge funds are holding shares in RNA
---
Avidity Biosciences Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$66.57 (108.68% Upside)
$66.57 (108.68% Upside)
Blogger Sentiment
Bullish
RNA Sentiment 100%
Sector Average 70%
Sector Average 70%
Insider Transactions
Sold Shares
Worth $1.3M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 3.1%
Last 30 Days ▼ 7.6%
Last 30 Days ▼ 7.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
124.96%
12-Months-Change
Fundamentals
Return on Equity
-27.76%
Trailing 12-Months
Asset Growth
186.27%
Trailing 12-Months
Company Description
Avidity Biosciences Inc
Avidity Biosciences Inc is a bio-technology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product candidate AOC 1001, is designed to treat a rare monogenic muscle disease.
---
RNA Stock 12 Month Forecast
Average Price Target
$66.57
▲(108.68% Upside)
Technical Analysis
Best Analysts Covering RNA
1 Year
1 Year Success Rate
12/21 ratings generated profit
1 Year Average Return
+128.42%
reiterated a buy rating last month
Copying Yanan Zhu's trades and holding each position for 1 Year would result in 57.14% of your transactions generating a profit, with an average return of +128.42% per trade.
---